NEW YORK (GenomeWeb News) – Response Biomedical said today that as a result of the termination of a collaboration with 3M and 3M Innovative Properties, it has regained the worldwide rights to Flu A+B and respiratory syncytial virus products.
Registering provides access to this and other free content.
Already have an account?Login Now.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
The White House seeks to update how biotechnology products are regulated.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.